For individuals with polymyositis, the presence of anti-SRP antibodies are associated with more prominent muscle weakness and atrophy.
Nas persoas con polimiosite, a presenza de anticorpos anti-SRP está asociada cunha debilidade muscular máis acusada e atrofia.